Skip to main content
Pharmaceutical Traceability Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Pharmaceutical Traceability Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Published: Dec 2023 176 Pages SKU: IRTNTR44798

Market Overview at a Glance

$17.92 B
Market Opportunity
23.44%
CAGR
23.38
YoY growth 2023-2024(%)

Pharmaceutical Traceability Market 2024-2028

The global pharmaceutical traceability market size is estimated to grow by USD 17.92 billion at a CAGR of 23.44% between 2023 and 2028. 

Globally, pharmaceutical companies are witnessing significant growth. The increasing prevalence and incidence of various chronic diseases, such as cancer, heart disease, diabetes, arthritis, chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and dementia, have increased the need to develop new drugs for their treatment. To treat these chronic diseases, pharmaceutical companies are increasingly focusing on developing generic and over-the-counter (OTC) drugs for various therapeutic applications. Further, rapid growth in drug development has increased the need for pharmaceutical companies to ensure brand protection due to counterfeiting. This is increasing the demand for various advanced technologies, including printing technologies and digital scanning, to protect pharmaceutical products from counterfeiting. Hence, the rising focus of pharmaceutical companies on brand protection is fostering the growth of the market during the forecast period.

Technavio has segmented the market into Type, Application, and Geography

  • The type segment is classified into barcode, RFID, GPS, and biometrics and others
  • The application segment is classified into pharmaceutical factories, hospitals, pharmacies, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Pharmaceutical Traceability Market During the Forecast Period?

Pharmaceutical Traceability Market Size

To learn more about this report, Download Report Sample

Pharmaceutical Traceability Market Segmentation by Type, Application and Geography Analysis

Type Analysis 

Barcode

The market share growth by the barcode segment will be significant during the forecast period. Barcodes are a series of vertical lines or bars with different widths that can be read by an optical scanner. The width and spacing of the bars represent binary data. The scanners are connected to computers. These scanners decode the barcodes to give the necessary information regarding the product.

Pharmaceutical Traceability Market Size

Get a glance at the market contribution of various segments Download PDF Sample

The barcode was the largest segment and was valued at USD 1.71 billion in 2018. Barcodes have been widely accepted by end-users because of their relatively lower cost when compared with RFID tags, their lightweight nature for ease of use, and their high accuracy levels on different material surfaces. Also, the government has promoted the use of barcodes in the pharmaceutical industry by introducing new initiatives and laws. Barcodes facilitate efficient tracking and identification of pharmaceutical products, aiding in supply chain management and reducing the risk of counterfeit drugs. Additionally, regulatory mandates for serialization and traceability further propel the growth of barcode solutions, making them a practical and widely accepted technology in pharmaceutical traceability efforts worldwide. Such factors will fuel the growth of the barcode segment of the market during the forecast period.

Application

Pharmaceutical factories

The pharmaceutical factories segment in the global pharmaceutical traceability market is witnessing increased demand due to several compelling factors. Firstly, regulatory compliance is a major driver in the growth of the pharmaceutical factories segment, as pharmaceutical manufacturers must adhere to stringent regulations to ensure the safety and authenticity of their products. Secondly, the rising prevalence of counterfeit drugs is a significant concern in the pharmaceutical industry.  Pharmaceutical factories are adopting traceability solutions to enhance operational efficiency and supply chain visibility. Accurate tracking and monitoring of the production processes, inventory, and distribution contribute to streamlined operations, reduced errors, and improved overall efficiency. Thus, stringent regulatory requirements, the need to combat counterfeit drugs, and a focus on enhancing operational efficiency will drive the growth of the global pharmaceutical traceability market through the pharmaceutical factories segment during the forecast period.

Hospitals

The hospital segment in the global pharmaceutical traceability market is witnessing increased demand due to various factors contributing to the overall safety, efficiency, and effectiveness of healthcare delivery. Patient safety is paramount in hospitals, and accurate traceability ensures that the right medications are administered to the right patients at the right time. Further, instances of increasing demand for pharmaceutical traceability in hospitals include the adoption of barcoding systems for patient identification and medication administration. Barcodes on patient wristbands and medications enable healthcare providers to verify patient identities and match them with prescribed medications, reducing the risk of errors during the administration process. This enhanced traceability in hospitals contributes to a safer and more efficient healthcare environment. Thus, increased emphasis on patient safety, efficient inventory management, and regulatory compliance will drive the demand for pharmaceutical traceability solutions in hospitals and will fuel the growth of the market in focus during the forecast period.

Regional Analysis

Pharmaceutical Traceability Market Share by Geography

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Rapid growth in the development of pharmaceutical drugs, technological advances, growing outsourcing of pharmaceutical manufacturing activities, rising concerns over the proliferation of counterfeit drugs, stringent regulations, and government initiatives, and the presence of prominent companies are the major factors driving the growth of the pharmaceutical traceability market in North America. In addition, pharmaceutical companies are outsourcing the development and manufacturing of pharmaceutical drugs to CMOs and contract development and manufacturing organizations (CDMOs), which is also increasing the demand for pharmaceutical traceability solutions and thereby boosting the growth of the pharmaceutical traceability market in North America.

Additionally, the DSCSA relates to the serialization of manufacturing drug products in the US and aims at tracking and tracing certain prescription drugs, which, in turn, has increased the demand for pharmaceutical traceability, thus spurring the growth of the pharmaceutical traceability market in North America during the forecast period.

Buy Full Report Now

Key Pharmaceutical Traceability Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

AlpVision SA  - The company offers pharmaceutical traceability solutions namely Pharmaledger.

  • Antares Vision S.p.A
  • Authentix Inc.
  • Avery Dennison Corp.
  • Axway Software SA
  • Bar Code India Ltd.
  • Cognex Corp.
  • Controlant hf.
  • Datalogic SpA
  • Dover Corp.
  • Impinj Inc.
  • Logista Pharma SAU
  • Mettler Toledo International Inc.
  • Optel Group, Oracle Corp.
  • rfxcel Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Pharmaceutical Traceability Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Pharmaceutical Traceability Market Drivers

Government regulations and initiatives regarding counterfeit drugs and medicines are notably driving the market growth. The rise in the global counterfeit of drugs and medicines has led the governments of various nations to introduce regulations to improve the traceability of pharmaceutical products. To reduce the growing market for counterfeit drugs, various governments and authorities in several nations have taken initiatives by declaring deadlines for implementing serialization by pharmaceutical companies. For example, in the US, the DSCSA made it mandatory that pharmaceutical companies introduce serial codes while manufacturing drugs, both at the saleable unit and case level, for manufacturers and re-packagers. 

Similarly, in July 2019, the Therapeutic Goods Administration (TGA) in Australia introduced new guidelines on product coding to reduce the counterfeiting of drugs in the country. Thus, the various government regulations and initiatives will drive the demand for the implementation of global traceability systems to overcome the various counterfeit issues and, in turn, will boost the growth of the market during the forecast period.

Significant Pharmaceutical Traceability Market Trends

The growth of online pharmacies is an emerging trend shaping the market growth. An online pharmacy or e-pharmacy uses an online platform for connecting a customer and seller for the sales of medicines. E-pharmacies are growing because of the discounts available on the products. Also, the customers can have easy access to the products because they are delivered to the customer as and when required. Some of the major factors driving the market are the growing number of Internet users and changing purchase preferences, that is, the growing number of online purchases.

Moreover, the sale of counterfeit drugs imposes a huge threat to the patient's life as well as the reputation of the company that manufactures the original drug. The growth of online pharmacies is the main source of counterfeit drugs; hence, this trend will give rise to the need for appropriate traceability systems in place and, in turn, will propel the growth of the market during the forecast period.

Major Pharmaceutical Traceability Market Challenges

The growing need for system integration is a significant challenge hindering the market growth. For a proper track and trace system, the state and central governments must be integrated into a single system. The integrated system must connect the government agencies, manufacturers, and other players in the supply chain. This task involves substantial setting up and implementation costs. Also, the integrated system becomes complex when more serial codes are assigned at unit levels and must be tracked throughout the supply chain. Also, the assignment of unique serial numbers at the unit level generates a huge amount of data.

Furthermore, huge investments are required for the development of such systems because updating existing hardware, software, and equipment is also required. The implementation of serialization can reach an estimated cost of around USD 2 million. The technical issues and difficulties in integrating the system will obstruct the adoption of such systems. Such challenges will slow down the growth of the market in focus during the forecast period.

Buy Now Full Report

Key Pharmaceutical Traceability Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Pharmaceutical Traceability Market Share by Geography

Global Pharmaceutical Traceability Market Customer Landscape

Segment Overview

The pharmaceutical traceability market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Barcode
    • RFID
    • GPS
    • Biometrics and others
  • Application Outlook
    • Pharmaceutical factories
    • Hospitals
    • Pharmacies
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Australia

Pharmaceutical Traceability Market Scope

Report Coverage

Details

Page number

176

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 23.44%

Market Growth 2024-2028

USD 17.92 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

23.38

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Germany, France, UK, and China

Competitive landscape

Leading Comapnies, Market Positioning of Comapnies, Competitive Strategies, and Industry Risks

Key companies profiled

AlpVision SA, Antares Vision S.p.A, Authentix Inc., Avery Dennison Corp., Axway Software SA, Bar Code India Ltd., Cognex Corp., Controlant hf., Datalogic SpA, Dover Corp., Impinj Inc., Logista Pharma SAU, Mettler Toledo International Inc., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, SATO Holdings Corp., TraceLink Inc., and Zebra Technologies Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Pharmaceutical Traceability Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the pharmaceutical traceability market  between 2024 and 2028
  • Precise estimation of the size of the pharmaceutical traceability market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of pharmaceutical traceability market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Pharmaceutical Traceability market growth will increase by $ 17.92 bn during 2024-2028.

The Pharmaceutical Traceability market is expected to grow at a CAGR of 23.44% during 2024-2028.

Pharmaceutical Traceability market is segmented by Type( Barcode, RFID, GPS, Biometrics and others) Application( Pharmaceutical factories, Hospitals, Pharmacies, Others)

AlpVision SA, Antares Vision S.p.A, Authentix Inc., Avery Dennison Corp., Axway Software SA, Bar Code India Ltd., Cognex Corp., Controlant hf., Datalogic SpA, Dover Corp., Impinj Inc., Logista Pharma SAU, Mettler Toledo International Inc., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, SATO Holdings Corp., TraceLink Inc., Zebra Technologies Corp. are a few of the key vendors in the Pharmaceutical Traceability market.

North America will register the highest growth rate of 37% among the other regions. Therefore, the Pharmaceutical Traceability market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Germany, France, UK, China

  • Growing concerns over counterfeit drugsCounterfeit drugs are medicines that are manufactured in a fraudulent manner or can be mislabeled with regard to the ingredients is the driving factor this market.
  • sources is the driving factor this market.
  • or other information. Illegal diversion of drugs is a major issue. Illegal diversion is the sale of drugs in countries apart from the ones where the drug is legally approved to be sold. Pharmaceutical theft can occur at any point in the supply chain is the driving factor this market.
  • like manufacturer is the driving factor this market.
  • wholesaler is the driving factor this market.
  • or distributor. Customers buy fake medicines either due to the lack of awareness or the low price of such drugs. This distribution of fake and counterfeit drugs has a huge impact on consumers. Counterfeit drugs lead to severe medical complications among people. Online sales of medicines contribute to more counterfeit drugs being distributed in the market. People purchase drugs from online sites because of the low cost is the driving factor this market.
  • more options is the driving factor this market.
  • and convenience. Currently is the driving factor this market.
  • the sudden outbreak of the COVID-19 pandemic has led to a rise in the circulation of counterfeit drugs is the driving factor this market.
  • especially in developing countries. The lockdown declared in many countries across the globe has led to disruptions in the supply of pharmaceutical raw materials and finished products. The demand for various drugs from people around the world has increased. The huge disparity between the demand for and supply of drugs is the driving factor this market.
  • owing to the shortage of raw materials as well as logistics challenges is the driving factor this market.
  • has increased the manufacturing and marketing of counterfeit drugs. For instance is the driving factor this market.
  • before June 15 is the driving factor this market.
  • 2020 is the driving factor this market.
  • the demand for hydroxychloroquine had increased among healthcare professionals across the globe to treat patients with COVID-19. The stockpiling of this drug by hospital facilities has led to a rise in the circulation of counterfeit products in low- and middle-income countries. Therefore is the driving factor this market.
  • the growth in the availability of counterfeit drugs has increased the demand for anti-counterfeiting technologies that utilize various traceability systems. This is the driving factor this market.
  • in turn is the driving factor this market.
  • will boost the growth of the global pharmaceutical traceability market during the forecast period. is the driving factor this market.

The Pharmaceutical Traceability market vendors should focus on grabbing business opportunities from the Barcode segment as it accounted for the largest market share in the base year.